ZURAMPIC is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceutica. The primary component is Lesinurad.
| Product ID | 0310-1475_dbd438e3-a7fb-4e93-a2d6-89d8c0647ed1 |
| NDC | 0310-1475 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZURAMPIC |
| Generic Name | Lesinurad |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-08-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207988 |
| Labeler Name | AstraZeneca Pharmaceutica |
| Substance Name | LESINURAD |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Urate Transport |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2016-10-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207988 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-08-11 |
| Marketing End Date | 2018-10-31 |
| Marketing Category | NDA |
| Application Number | NDA207988 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-12-22 |
| Marketing End Date | 2015-12-22 |
| Marketing Category | NDA |
| Application Number | NDA207988 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-10-03 |
| Marketing End Date | 2019-02-28 |
| Ingredient | Strength |
|---|---|
| LESINURAD | 200 mg/1 |
| SPL SET ID: | 92d614a3-760d-492c-930d-22f91ff016b1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-1475 | ZURAMPIC | lesinurad |
| 70785-011 | Zurampic | lesinurad |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZURAMPIC 86488044 4865620 Live/Registered |
AstraZeneca AB 2014-12-22 |
![]() ZURAMPIC 86338542 4849004 Live/Registered |
AstraZeneca AB 2014-07-16 |